Mutations of DNMT3A and SF3B1, a component of spliceosome complex frequently mutated in RARS, have been reported to occur concurrently more often than expected by chance in lower-risk MDS patients [17]. This evidence concerns the gene SF3B1 and myelodysplastic syndrome with ring sideroblasts.